宫颈癌放化疗后局部失败事件的系统研究:了解基线侧解剖腔室受累的影响。

IF 6.5 1区 医学 Q1 ONCOLOGY
Lucas Gomes Sapienza, Gustavo Guitmann, Christopher G Morris, Paul G Okunieff, Michelle Suzanne Ludwig, Maria José Leite Gomes, Isidore Daniel Benrubi, Karina E Hew
{"title":"宫颈癌放化疗后局部失败事件的系统研究:了解基线侧解剖腔室受累的影响。","authors":"Lucas Gomes Sapienza, Gustavo Guitmann, Christopher G Morris, Paul G Okunieff, Michelle Suzanne Ludwig, Maria José Leite Gomes, Isidore Daniel Benrubi, Karina E Hew","doi":"10.1016/j.ijrobp.2025.09.015","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To dissect the local failure (LF) events, including specific rates by anatomical compartments, after definitive chemoradiotherapy for locally advanced cervical cancer (LACC).</p><p><strong>Methods: </strong>Records of all consecutive women with LACC treated with definitive chemoradiotherapy and image-guided adaptive brachytherapy (IGABT) were reviewed, focusing on the local disease status. No patient received external-beam radiotherapy (EBRT) parametrial boost. Incidence estimations, timing analysis (true persistent disease [TP]) versus new recurrence [NR]), calculations of LF rates by anatomical compartments (at the time of LF detection), and test of association of compartment-specific LF with baseline (at diagnosis) involvement (adjusted odds ratio [aOR]), were performed.</p><p><strong>Results: </strong>Among the 225 patients included (75% FIGO III-IV; 32% IC/IS BT use; median FU 46.2 months), 34 LFs occurred (24 TP; 10 NR), involving 92 anatomical compartments. Isolated LF was the first relapse in 55.9% (19/34), with no events after 3 years, resulting in 6.2% 3-year/5-year overall NR and 16.3% 3-year/5-year overall LF (NR + TP) rates. TP had worse survival compared to NR (2y-OS: 19.1% vs. 72.9%, p=0.04). The most involved compartments were the cervix (79.4%), parametrium (PMT) (61.8%), uterine corpus (33.3%), bladder (14.7%), vagina (11.8%), and mesorectum (2.9%). Recurrence followed the cardinal (CL), uterosacral (USL), and pubocervical (PCL) directions in 58.8%, 35.3%, and 23.5% of cases, respectively. Only two intact PMT at diagnosis developed ipsilateral LF (1.1%, 2/181, CL only), while baseline ipsilateral PMT involvement with hydronephrosis was associated with ipsilateral LF (aOR 22.2, p<0.01, rate: 21.3%, 10/47, involving CL±PCL±USL), but not with contralateral LF (aOR 0.4, p=0.28).</p><p><strong>Conclusion: </strong>In the non-operative setting, the lateral PMT is the second most involved anatomical compartment by LF (>60%) after the cervix (80%). An intact baseline PMT has low frequency (1%) and limited extension (CL only) of ipsilateral failure. In contrast, baseline hydronephrosis is strongly associated with extensive ipsilateral PMT relapse, requiring side-specific treatment intensification.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.5000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A systematic study on local failure events post chemoradiotherapy for cervical cancer: understanding the impact of baseline lateral anatomical compartment involvement.\",\"authors\":\"Lucas Gomes Sapienza, Gustavo Guitmann, Christopher G Morris, Paul G Okunieff, Michelle Suzanne Ludwig, Maria José Leite Gomes, Isidore Daniel Benrubi, Karina E Hew\",\"doi\":\"10.1016/j.ijrobp.2025.09.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To dissect the local failure (LF) events, including specific rates by anatomical compartments, after definitive chemoradiotherapy for locally advanced cervical cancer (LACC).</p><p><strong>Methods: </strong>Records of all consecutive women with LACC treated with definitive chemoradiotherapy and image-guided adaptive brachytherapy (IGABT) were reviewed, focusing on the local disease status. No patient received external-beam radiotherapy (EBRT) parametrial boost. Incidence estimations, timing analysis (true persistent disease [TP]) versus new recurrence [NR]), calculations of LF rates by anatomical compartments (at the time of LF detection), and test of association of compartment-specific LF with baseline (at diagnosis) involvement (adjusted odds ratio [aOR]), were performed.</p><p><strong>Results: </strong>Among the 225 patients included (75% FIGO III-IV; 32% IC/IS BT use; median FU 46.2 months), 34 LFs occurred (24 TP; 10 NR), involving 92 anatomical compartments. Isolated LF was the first relapse in 55.9% (19/34), with no events after 3 years, resulting in 6.2% 3-year/5-year overall NR and 16.3% 3-year/5-year overall LF (NR + TP) rates. TP had worse survival compared to NR (2y-OS: 19.1% vs. 72.9%, p=0.04). The most involved compartments were the cervix (79.4%), parametrium (PMT) (61.8%), uterine corpus (33.3%), bladder (14.7%), vagina (11.8%), and mesorectum (2.9%). Recurrence followed the cardinal (CL), uterosacral (USL), and pubocervical (PCL) directions in 58.8%, 35.3%, and 23.5% of cases, respectively. Only two intact PMT at diagnosis developed ipsilateral LF (1.1%, 2/181, CL only), while baseline ipsilateral PMT involvement with hydronephrosis was associated with ipsilateral LF (aOR 22.2, p<0.01, rate: 21.3%, 10/47, involving CL±PCL±USL), but not with contralateral LF (aOR 0.4, p=0.28).</p><p><strong>Conclusion: </strong>In the non-operative setting, the lateral PMT is the second most involved anatomical compartment by LF (>60%) after the cervix (80%). An intact baseline PMT has low frequency (1%) and limited extension (CL only) of ipsilateral failure. In contrast, baseline hydronephrosis is strongly associated with extensive ipsilateral PMT relapse, requiring side-specific treatment intensification.</p>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijrobp.2025.09.015\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.09.015","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨局部晚期宫颈癌(LACC)放化疗后局部失败(LF)事件,包括解剖室的具体发生率。方法:回顾所有连续接受明确放化疗和图像引导适应性近距离放疗(IGABT)的女性LACC患者的记录,重点关注局部疾病状况。无患者接受外束放疗(EBRT)参数强化。进行了发病率估计、时间分析(真实持续疾病[TP]与新发复发[NR])、按解剖室计算LF发生率(在LF检测时),以及检测室特异性LF与基线(诊断时)累及的相关性(调整优势比[aOR])。结果:纳入的225例患者中(75% FIGO III-IV; 32%使用IC/IS BT;中位FU 46.2个月),发生34例LFs(24例TP; 10例NR),涉及92个解剖室。孤立性LF首次复发率为55.9%(19/34),3年后无复发,3年/5年总NR为6.2%,3年/5年总LF (NR + TP)率为16.3%。TP患者的生存率较NR患者差(2年生存率:19.1%比72.9%,p=0.04)。受累最多的是宫颈(79.4%)、子宫内膜(61.8%)、子宫体(33.3%)、膀胱(14.7%)、阴道(11.8%)和肠系膜(2.9%)。复发分别发生在枢机(CL)、子宫骶(USL)和耻骨颈椎(PCL)方向,分别占58.8%、35.3%和23.5%。诊断时仅有2例完整PMT发展为同侧LF(1.1%, 2/181,仅CL),而基线时伴有肾积水的同侧PMT与同侧LF相关(aOR 22.2, p)。结论:在非手术情况下,侧PMT是继子宫颈(80%)之后第二大累及LF的解剖腔室(bbb60 %)。一个完整的基线PMT有低频率(1%)和有限的扩展(仅CL)的同侧失败。相比之下,基线肾盂积水与广泛的同侧PMT复发密切相关,需要加强侧边特异性治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A systematic study on local failure events post chemoradiotherapy for cervical cancer: understanding the impact of baseline lateral anatomical compartment involvement.

Purpose: To dissect the local failure (LF) events, including specific rates by anatomical compartments, after definitive chemoradiotherapy for locally advanced cervical cancer (LACC).

Methods: Records of all consecutive women with LACC treated with definitive chemoradiotherapy and image-guided adaptive brachytherapy (IGABT) were reviewed, focusing on the local disease status. No patient received external-beam radiotherapy (EBRT) parametrial boost. Incidence estimations, timing analysis (true persistent disease [TP]) versus new recurrence [NR]), calculations of LF rates by anatomical compartments (at the time of LF detection), and test of association of compartment-specific LF with baseline (at diagnosis) involvement (adjusted odds ratio [aOR]), were performed.

Results: Among the 225 patients included (75% FIGO III-IV; 32% IC/IS BT use; median FU 46.2 months), 34 LFs occurred (24 TP; 10 NR), involving 92 anatomical compartments. Isolated LF was the first relapse in 55.9% (19/34), with no events after 3 years, resulting in 6.2% 3-year/5-year overall NR and 16.3% 3-year/5-year overall LF (NR + TP) rates. TP had worse survival compared to NR (2y-OS: 19.1% vs. 72.9%, p=0.04). The most involved compartments were the cervix (79.4%), parametrium (PMT) (61.8%), uterine corpus (33.3%), bladder (14.7%), vagina (11.8%), and mesorectum (2.9%). Recurrence followed the cardinal (CL), uterosacral (USL), and pubocervical (PCL) directions in 58.8%, 35.3%, and 23.5% of cases, respectively. Only two intact PMT at diagnosis developed ipsilateral LF (1.1%, 2/181, CL only), while baseline ipsilateral PMT involvement with hydronephrosis was associated with ipsilateral LF (aOR 22.2, p<0.01, rate: 21.3%, 10/47, involving CL±PCL±USL), but not with contralateral LF (aOR 0.4, p=0.28).

Conclusion: In the non-operative setting, the lateral PMT is the second most involved anatomical compartment by LF (>60%) after the cervix (80%). An intact baseline PMT has low frequency (1%) and limited extension (CL only) of ipsilateral failure. In contrast, baseline hydronephrosis is strongly associated with extensive ipsilateral PMT relapse, requiring side-specific treatment intensification.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信